JPRN-UMIN000021116已完成未知
Clinical trial phase 2 evaluating postoperative visual functions in eyes with epiretinal membrane with good visual acuity better than 0.9 decimal unit - Evaluating postoperative visual functions in eyes with ERM with good visual acuity better than 0.9 decimal unit
ihon University hospita0 个研究点目标入组 40 人开始时间: 2016年2月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.vitrectomized eye 2.eyes with intraoccular inflammation or retinal vascular diseases
研究者
相似试验
进行中（未招募）
1 期
A trial comparing chemotherapy and bevacizumab or lapatinib with chemotherapy alone for cancer of the stomach, oesophagus or the junction of the stomach and oesophagusPatients with histologically verfied lower oesophageal, Siewert Type I, II or III oesophagogastric junction or gastric adenocarcinoma.Type III or gastric tumours should be stage 1b (T1N1, T2a/bN0), II,III or stage IV (T4 N1orN2 M0). Lower oesophageal, Type I and II tumours should be stage II to stage IVa (T1N1, T2N1, T3N0-1, but not T2N0). T4 tumours are eligible if they involve the crura or invade the mediatinal pleural only.The tumour should be operableMedDRA version: 18.0Level: PTClassification code 10017758Term: Gastric cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.0Level: PTClassification code 10062878Term: Gastrooesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2006-000811-12-GBMedical Research Council Clinical Trials Unit1,100
进行中（未招募）
1 期
PANCEP-1Pancreatic cancerCTIS2023-506979-10-00Vaestra Goetalandsregionen50
已完成
不适用
A randomized phase II trial of postoperative adjuvant therapy with imanitib for 1 Year versus 6 months in patients with gastrointestinal stromal tumorsGastrointestinal stromal tumor (GIST)JPRN-UMIN000000950Kinki GIST Study Group80
进行中（未招募）
1 期
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckCTIS2024-513206-65-00Groupe Oncologie Radiotherapie Tete Cou674
进行中（未招募）
1 期
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckSquamous cell carcinoma treated by primary surgeryStage III, stage IV (American Joint Committee on Cancer 7th edition)Oral cavity, oropharynx, hypopharynx or larynxMedDRA version: 21.0Level: PTClassification code 10060121Term: Squamous cell carcinoma of head and neckSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-004936-13-PLGORTEC680